drugset / Trial / NCT00187044

Evaluation of the Safety of a Polyvalent Virus in Healthy Adults

NCT00187044 ↗

Phase 1 Completed 18 enrolled St. Jude Children's Research Hospital
NaSingle-groupOpen-labelPrevention

Summary

This is a research study to evaluate the safety of a vaccine to protect people from HIV infection. Human Immunodeficiency Virus (HIV) is the cause of AIDS (Acquired Immune Deficiency Syndrome). AIDS is one of the most serious viral infections of our time. It is believed that all persons who contract HIV will eventually develop AIDS. Because of this, we are trying to develop new ways to prevent infection with HIV. The vaccine that will be tested in this study has been prepared from a small part of the HIV. The part of the HIV used in this vaccine is the "envelope" or coating part of the virus. In this study, researchers will evaluate how well the vaccine is tolerated, how much vaccine should be given, and determine if any side effects occur in response to the vaccination.

Timeline

Start
1997-10
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject PolyEnv1 Vaccine 0.8 ml Subcutaneous
Subject PolyEnv1 Vaccine 1e+07 unknown Subcutaneous